Database at Stanford University that tracks mutations of HIV
HIV Drug Resistance Database, also known as Stanford HIV RT and Protease Sequence Database, is a database at Stanford University that tracks 93 common mutations of HIV. It has been recompiled in 2008 listing 93 common mutations, after its initial mutation compilation in 2007 of 80 mutations. The latest list utilizes data from other laboratories in Europe, Canada and the United States including more than 15,000 sequences from untreated individuals.[1]
^Physorg:New Stanford list of HIV mutations vital to tracking AIDS epidemic
and 18 Related for: HIV Drug Resistance Database information
are known for their increased virulence or drugresistance to different medications used to treat HIV. HIV-2 viruses are generally considered to be less...
and Australian tea trees. Most of the antiviral drugs now available are designed to help deal with HIV, herpes viruses, the hepatitis B and C viruses,...
Multiple drugresistance (MDR), multidrug resistance or multiresistance is antimicrobial resistance shown by a species of microorganism to at least one...
Antimicrobial resistance (AMR) occurs when microbes evolve mechanisms that protect them from the effects of antimicrobials (drugs used to treat infections)...
response in the patient. Drugresistance, such as antimicrobial resistance or antineoplastic resistance, may make the first-line drug ineffective, especially...
mortality, reduction in relapses, preventing drugresistance to ATT and reduction in occurrence of HIV-associated infections other than TB. The disadvantages...
"Antiretroviral DrugResistance and Resistance Testing in Pregnancy | Antepartum Care | Perinatal | ClinicalInfo". Clinical Info HIV gov. Office of AIDS...
23 July 2010. Stanford University DrugResistanceDatabase. Koziel MJ, Peters MG (April 2007). "Viral hepatitis in HIV infection". The New England Journal...
with a high prevalence of HIV and poor infection control; in other countries where XDR-TB strains have arisen, drug-resistance has arisen from mismanagement...
of approximately $10,000 per patient per year for the drug, well out of reach of nearly all HIV positive persons. Several days following this demonstration...
g., patients with advanced HIV receiving treatment for thrush or esophageal Candida infection). In C. albicans, resistance occurs by way of mutations...
HIVResistance Response Database Initiative (RDI) was formed in 2002 to use artificial intelligence (AI) to predict how patients will respond to HIV drugs...
(HAART) and is used to prevent the likelihood of HIVresistance. As of 2019, the standard is a three-drug once-daily oral treatment that can include AZT...
inventor was issued in 1979. Vince later invented abacavir, an nRTI drug for HIV patients. Elion was awarded the 1988 Nobel Prize in Medicine, partly...
experimental HIVdrugs, called CCR5 receptor antagonists, have been designed to interfere with binding between the Gp120 envelope protein and the HIV co-receptor...
during this step that mutations may occur. Such mutations may cause drugresistance. Retroviruses, also referred to as class VI ssRNA-RT viruses, are RNA...
sulfamethoxazole or dapsone it may be used for Pneumocystis pneumonia in people with HIV/AIDS. It is taken orally (swallowed by mouth). Common side effects include...
Global Information